Dimensional Fund Advisors
BHVN

Dimensional Fund Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Dimensional Fund Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45,333
Closed -$6.85M – 3580
2022
Q3 		$6.85M Sell
45,333
-46,030
-50% -$6.82M ﹤0.01% 2310
2022
Q2 		$13.3M Buy
91,363
+8,764
+11% +$1.12M ﹤0.01% 2080
2022
Q1 		$9.79M Buy
82,599
+29,413
+55% +$3.67M ﹤0.01% 2304
2021
Q4 		$7.33M Sell
53,186
-20,990
-28% -$2.67M ﹤0.01% 2426
2021
Q3 		$10.3M Buy
74,176
+57,543
+346% +$7.18M ﹤0.01% 2316
2021
Q2 		$1.61M Buy
16,633
+8
+0% +$649 ﹤0.01% 2929
2021
Q1 		$1.14M Sell
16,625
-10,335
-38% -$836K ﹤0.01% 2987
2020
Q4 		$2.31M Sell
26,960
-2,648
-9% -$224K ﹤0.01% 2768
2020
Q3 		$1.93M Buy
+29,608
New +$1.94M ﹤0.01% 2758

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Dimensional Fund Advisors's BHVN Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 45,333 shares — an estimated $6.85M sold.

Dimensional Fund Advisors first reported a position in BHVN in Q3 2020 and held it in 9 quarters. The position peaked at $13.3M in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 45,333 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $6.85M.
  • Dimensional Fund Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2020 and held it in 9 quarters.
  • Dimensional Fund Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $13.3M in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.